Holocene Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,436,672
| Closed | -$164M | – | 793 |
|
|
2025
Q3 | $164M | Buy |
+2,436,672
| New | +$193M | 0.37% | 65 |
|
|
2025
Q2 | – | Sell |
-816,063
| Closed | -$55.7M | – | 789 |
|
|
2025
Q1 | $55.7M | Sell |
816,063
-774,007
| -49% | -$63.2M | 0.16% | 158 |
|
|
2024
Q4 | $124M | Buy |
1,590,070
+1,560,517
| +5,280% | +$116M | 0.4% | 66 |
|
|
2024
Q3 | $1.98M | Sell |
29,553
-1,743,682
| -98% | -$143M | 0.01% | 544 |
|
|
2024
Q2 | $201M | Buy |
1,773,235
+137,111
| +8% | +$17.3M | 0.84% | 27 |
|
|
2024
Q1 | $227M | Sell |
1,636,124
-36,790
| -2% | -$4.62M | 0.83% | 28 |
|
|
2023
Q4 | $208M | Sell |
1,672,914
-912,983
| -35% | -$93.3M | 0.81% | 28 |
|
|
2023
Q3 | $241M | Buy |
2,585,897
+981,344
| +61% | +$111M | 1.06% | 15 |
|
|
2023
Q2 | $206M | Buy |
1,604,553
+93,377
| +6% | +$11.3M | 0.88% | 22 |
|
|
2023
Q1 | $176M | Buy |
1,511,176
+122,778
| +9% | +$13.7M | 0.86% | 23 |
|
|
2022
Q4 | $157M | Sell |
1,388,398
-343,669
| -20% | -$37.7M | 0.96% | 25 |
|
|
2022
Q3 | $140M | Sell |
1,732,067
-151,399
| -8% | -$12.8M | 0.89% | 22 |
|
|
2022
Q2 | $140M | Buy |
1,883,466
+179,690
| +11% | +$16.4M | 0.85% | 32 |
|
|
2022
Q1 | $218M | Buy |
1,703,776
+827,808
| +95% | +$90.6M | 1.14% | 15 |
|
|
2021
Q4 | $118M | Buy |
875,968
+127,052
| +17% | +$18.3M | 0.61% | 48 |
|
|
2021
Q3 | $102M | Sell |
748,916
-570,872
| -43% | -$72M | 0.56% | 49 |
|
|
2021
Q2 | $141M | Sell |
1,319,788
-202,064
| -13% | -$19.4M | 0.8% | 26 |
|
|
2021
Q1 | $137M | Buy |
1,521,852
+750,284
| +97% | +$70.4M | 0.86% | 20 |
|
|
2020
Q4 | $71.3M | Buy |
771,568
+637,748
| +477% | +$56.9M | 0.45% | 71 |
|
|
2020
Q3 | $13.8M | Sell |
133,820
-60,308
| -31% | -$6.3M | 0.1% | 210 |
|
|
2020
Q2 | $19.7M | Sell |
194,128
-999,648
| -84% | -$89.4M | 0.17% | 149 |
|
|
2020
Q1 | $80.4M | Buy |
1,193,776
+679,468
| +132% | +$42.3M | 0.86% | 30 |
|
|
2019
Q4 | $28.1M | Sell |
514,308
-494,916
| -49% | -$23.5M | 0.25% | 111 |
|
|
2019
Q3 | $37.7M | Buy |
+1,009,224
| New | +$39.2M | 0.39% | 80 |
|
|
2018
Q2 | – | Sell |
-18,552
| Closed | -$344K | – | 603 |
|
|
2018
Q1 | $344K | Sell |
18,552
-49,156
| -73% | -$727K | 0.01% | 371 |
|
|
2017
Q4 | $971K | Buy |
+67,708
| New | +$880K | 0.02% | 147 |
|
Other funds holding DXCM
JSC
Holocene Advisors's DXCM Position: Q4 2025 in Review
Holocene Advisors sold out of DexCom (DXCM) in Q4 2025, closing a stake of 2,436,672 shares — an estimated $164M sold.
Holocene Advisors first reported a position in DXCM in Q4 2017 and held it in 26 quarters. The position peaked at $241M in Q3 2023. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.
- Holocene Advisors reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
- Holocene Advisors sold 2,436,672 DexCom shares in Q4 2025, an estimated $164M.
- Holocene Advisors first reported a position in DexCom in Q4 2017 and held it in 26 quarters.
- Holocene Advisors's DexCom position peaked at $241M in Q3 2023.
- 920 funds tracked by Wall St. Rank held DexCom as of Q4 2025.
Based on Holocene Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.